Browsing: Expanding

Whole-exome sequencing (WES) is widely used in both clinical and research settings, but current implementations require trade-offs between genomic breadth,…

The research community is as diverse as the scientific questions they study. For mid-sized labs, core facilities, and emerging biotech…

Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…

“Glow inside out” is an apt phrase when communicating the benefits of beauty-from-within products, but the messaging must evolve according…

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products…